Welcome to our dedicated page for TAT Technologies Ltd. news (Ticker: $TATT), a resource for investors and traders seeking the latest updates and insights on TAT Technologies Ltd. stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect TAT Technologies Ltd.'s stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of TAT Technologies Ltd.'s position in the market.
TAT Technologies (NASDAQ: TATT) reported unaudited Q1 2024 results, showcasing significant growth. Revenues surged by 35.3% to $34.1 million, up from $25.2 million in Q1 2023. Gross profit increased by 65.1% to $7.1 million, and gross margin improved to 20.7%. Adjusted EBITDA grew by 76.8% to $3.7 million, while operating income soared by 133% to $2.2 million. Net income saw a remarkable increase of 221% to $2.1 million. However, cash flow from operating activities was negative $3.5 million, contrasting with a positive $1.7 million in Q1 2023.